Case File
efta-01583240DOJ Data Set 10OtherEFTA01583240
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01583240
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Standing Instructions for Derivatives Collateral Transfers
and Margin Loan Form - Overview and Instructions
J.P. Morgan
D. Transfers from the Margin Account to the Derivatives Account (Optional)
Further, by checking the boxes below, the undersigned has elected to euttionze, direct, and empower J.P. Mogan to take the
following additional actions on the undersigned's behalf, which J.P. Morgan may do, but ts not obligated to do, and to make
adjustments for any erroneous entries.
If the cash maintained in the undersigned's Asset With Brokerage Derivatives Account and, if the undersigned has elected, the
undersigned's Asset With Brokerage Account, are insufficient to meet any Derivatives Margin Call, then J.P. Morgan Is initotirized,
without notice to the undersigned, to debit sucn amounts and transfer such assets (as determined by J.P. Morgan to be necessary to
satisfy any Derivatives Margin Call) from the undersigned's ).P. Morgan account noted below ('Margin Acernt") and, if applicable,
any cash proceeds from me sale of any money market funds, to the undersigned's Asset With Brokerage Derivatives Account.
Margin Account Information:
This authorization is for the undersigned's existing account. Enter AccOUnt Numbe:
K This authorization is for an account that will be established by the undersigned in connection with the execytion of this author tzation.
The undersigned hereby agrees that upon the account's establishment and the assignment of an account number, J.P. Morgan will
send the undersigned a confirmation statement verifying the account's establishment, the account number, and that this
authorization applies to the account.
E. Return of Excess Cash from the Derivatives Account to Pay Down Margin Loan (Optional)
Further, by checldng the box below, the undersigned has elected to authorize, direct, and empower 1.P. Morgan to take the following
additional actions on the undersigned's behalf, which 3.P. Morgan may do, but is not obligated to make adjustments for any erroneous
entries.
K If the amount of the undersigned's Derivatives Collateral on any day exceeds the aggregate amount of tht undersigned's Derivatives
Obligations to the J.P. Morgan entlty(les) that is/are a party to such Derivatives Obligations, then ).P. Morgan is authorized, without
notice to the undersigned, to transfer from the undersigned's Asset With Brokerage Derivatives Account such exams cash to pay any
debit balance owing with respect to the undersigned's Margin Account.
The undersigned acknowledges that if the undersigned does not elect the foregoing authorization, then J.P. Morgan may
still make such transfers If the undersigned, either orally or In a saga rate writing, directs ).P. Morgan to do so. AO other
terms and conditions applicable to the Margin Account are set out In the agreement entered Into by the undersigned to
purchase securities on margin, and to otherwise borrow against securities (together with any amendments,
restatements, modifications, or supplements, the "Margin Account Agreement'), and the foregoing authorization is
subject to the terms of the Margin Account Agreement.
F. Signature
AU account owners ant required to sign below.
The undersigned acknowledges that this authorization is subject to the Genera) Terms for Acounts and Services, as the same may be
amended, restated, supplemented, or otherwise modified from time to time in accordance with Its terms. This authorization Is to
remain in full force and effect until written notice of its revocation is received by LP. Morgan, in such time and in such manner as to
afford ).P. Morgan a reasonable opportunity to act on it.
En >
Signature
JEFFREY E. EPSTEIN
Date
Name (Print)
Signature
Date
Name (Print)
Signature
Date
Nano (Pnnt)
Signature
Date
'lame !Print)
).P. Morgan use Only
Title
SPN
CAS
Page 2 of 2
Banker/Investor
4/13
131
Confidential Treatment Requested by JPMorgan Chase
JPM-SDNY-00062876
EFTA01583240
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.